Doxycycline vs Nivolumab

## Doxycycline vs Nivolumab: Overview

This comparison examines the pharmacological differences between **Doxycycline** and **Nivolumab**.

## Mechanism of Action

**Doxycycline**: Inhibits bacterial protein synthesis by binding 30S ribosomal subunit.

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

## Pharmacokinetics

**Half-life**: Doxycycline — 18-22 hours; Nivolumab — 27 days.

## Chemical Properties

**Molecular Formula**: Doxycycline — C22H24N2O8; Nivolumab — N/A.

**Molecular Weight**: Doxycycline — 444.4350 g/mol; Nivolumab — N/A.

**Type**: Doxycycline — Small molecule; Nivolumab — Antibody.